Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 17, 2013 07:00 ET | Source: Talon Therapeutics, Inc.

Spectrum Pharmaceuticals Acquires Talon Therapeutics

SOUTH SAN FRANCISCO, Calif., July 17, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) today announced that a subsidiary of Spectrum Pharmaceuticals, Inc. (Nasdaq:SPPI) entered into an...
May 15, 2013 17:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results

SOUTH SAN FRANCISCO, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the three months ended March 31, 2013. Corporate...
April 01, 2013 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results

SOUTH SAN FRANCISCO, Calif., April 1, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the fourth quarter and year ended December 31, 2012. 2012...
March 19, 2013 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics to Host a Conference Call to Report 2012 Financial Results and Business Update on April 1, 2013

SOUTH SAN FRANCISCO, Calif., March 19, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCQB:TLON) will host a conference call on Monday, April 1, 2013 at 9:00AM PDT, to discuss 2012 financial...
January 07, 2013 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics Announces Review of Strategic Alternatives

SOUTH SAN FRANCISCO, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
January 04, 2013 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics Appoints Elizabeth Weatherman to Board of Directors

SOUTH SAN FRANCISCO, Calif., Jan. 4, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics (OTCBB:TLON), a biopharmaceutical company focused on expert and efficient clinical development of product candidates...
December 05, 2012 09:00 ET | Source: Talon Therapeutics, Inc.

Marqibo(R) Data to be Presented in Three Scientific Sessions and at a Product Theater During the American Society of Hematology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON), an oncology and oncology supportive care focused biopharmaceutical company, today announced that...
November 27, 2012 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics Announces Publication of the Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) RALLY Study in the Journal of Clinical Oncology (JCO)

Data supported FDA accelerated approval of Marqibo (http://jco.ascopubs.org/) Data published online ahead of print as a Rapid Communication Data represents the per protocol, planned...
November 14, 2012 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports Third Quarter 2012 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and nine months ended September 30, 2012. "FDA...
November 13, 2012 12:44 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics' Recently Approved Marqibo Presented at 2012 Chemotherapy Foundation Symposium

"The Role of Vincristine Sulfate Liposome Injection in Hematologic Malignancies Data" presented by Dr. Dan Douer of Memorial Sloan-Kettering on Nov. 7 Marqibo is indicated for the treatment...